Want more information on Api Ivermectin Manufacturer? Feel free to contact us.
Ivermectin, a drug once touted by conservatives as a treatment for Covid, does not meaningfully improve the recovery time for people with mild to moderate cases, according a large clinical trial published in a peer-reviewed journal.
People who took ivermectin recovered from Covid in 12 days while people who didn't take the drug recovered in 13 days, according to the study published in the Journal of the American Medical Association on Friday. Ivermectin has been approved to treat parasitic worms in humans, but it's primarily used as a dewormer for horses.
"Among outpatients with mild to moderate COVID-19, treatment with ivermectin, compared with placebo, did not significantly improve time to recovery," the team of scientists led by Duke University School of Medicine wrote. "These findings do not support the use of ivermectin in patients with mild to moderate COVID-19," they concluded.
Early on in the pandemic when there were few treatment options, ivermectin gained national notoriety when a couple of groups of conservative doctors, including Front Line COVID-19 Critical Care Alliance and America's Frontline Doctors began touting the drug on social media and elsewhere as a treatment for Covid. But there was little data backing up those claims and a study by Dr. Pierre Kory, a critical care physician in Wisconsin and president of the critical care alliance, claiming it was an effective treatment was later retracted for having flawed data.
For more information, please visit Praziquantel Injectable Msds.
The latest trial looked at 817 people who took ivermectin tablets for three days and compared them to 774 who received a placebo. The participants who took ivermectin received a daily dose based on their weight. Recovery from Covid was defined as three consecutive days without symptoms.
One person died in the ivermectin group while not one person who received the placebo passed away. The number of people hospitalized in each group was the same at nine participants each.
The study was conducted across 93 sites in the U.S. from June 2021 through May 2022 when the delta variant and then the omicron strain were dominant.
The Food and Drug Administration has not authorized ivermectin for treating or preventing Covid and has repeatedly warned people against taking the drug for anything other than its approved purpose.
If you are looking for more details, kindly visit China Avermectin B1 and Dogs.